BioSpace News Archive

Infection Control in Hospitals Still Promises to Grow | Expert view

Infection control is an essential process of every healthcare organization. As there is a constant rise in infectious diseases around the world, infection control professionals are facing various challenges.

March 17, 2022
·
2 min read
Biotech Bay

Gator Bio Expands the Portfolio of AAV Characterization Solutions with the launch of AAV9 probes for Gene Therapy Research

Gator Bio, Inc. announced the launch of Gator™ AAV9 probe for quantitation and kinetics using GatorPrime™ and GatorPlus™ next generation biolayer interferometry instruments.

March 17, 2022
·
2 min read
Genetown

Volta Labs Launches with $20 Million in Series A

Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, announced it raised $20 million in a Series A funding.

March 17, 2022
·
4 min read
Pharm Country

Nectar Secures $8M in Seed Funding to Revolutionize Allergy Care

Nectar, an innovative and comprehensive allergy care platform, announced their $8 million seed round led by Juxtapose and Obvious Ventures, who are co-building the company alongside Founder and CEO Kenneth Chahine, Ph.D.

March 17, 2022
·
5 min read
Business

Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Virios Therapeutics, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2021.

March 17, 2022
·
8 min read
Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the publication of an article entitled “ BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Study ” in the prestigious American Journal of Respiratory and Critical Care Medicine – which has an impact factor of 21.4.

March 17, 2022
·
8 min read
Business

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Cullinan Oncology, Inc. today reported on recent and upcoming business highlights and announced its financial results for the fourth quarter and full year ended December 31, 2021.

March 17, 2022
·
12 min read
Business

Century Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates

“Throughout 2021, we continued to make steady progress in developing our comprehensive, next-generation iPSC-based cell therapy platform, executed on our powerful discovery engine, and we believe we are positioned to transition to a clinical stage company in 2022.

March 17, 2022
·
10 min read
Business

Zepp Health Corporation Reports Fourth Quarter and Full Year 2021 Unaudited Financial Results

Zepp Health Corporation (“Zepp” or the “Company”) (NYSE: ZEPP) today reported revenue of RMB1.7 billion ( US$260.7 million ); GAAP diluted net income per share of RMB0.14 (US$0.02) ; and GAAP diluted net income per ADS of RMB0.55 (US$0.09) for the fourth quarter ended December 31, 2021.

March 17, 2022
·
23 min read
Bio NC

New Labcorp Offering Makes Detecting, Measuring Unintentional Gluten Consumption Simple and Effective

Labcorp is the first U.S. commercial laboratory to offer a new test developed by Immundiagnostik, Inc. to help individuals detect and quantify unintentional gluten consumption.

March 17, 2022
·
5 min read